Search Results
138 items found for "Wnt pathway inhibition"
- Gi/o GPCRs drive the formation of actin-rich tunneling nanotubes in cancer cells via a Gβγ/PKCα/FARP1/Cdc42 axis
This effect is reduced by pertussis toxin (PTX) and GUE1654, a biased antagonist for the Gβγ pathway dependent on the transactivation of the epidermal growth factor receptor (EGFR) and impaired by PI3K inhibition a link between Gi/o-coupled GPCRs and TNT development, and sheds light into the intricate signaling pathways
- A2aR on lung adenocarcinoma cells: A novel target for cancer therapy via recruiting and regulating tumor-associated macrophages
receptor (A2aR), a typical GPCR with a high affinity for adenosine, is widely expressed on immune cells, inhibiting We hypothesize that blocking A2aR on LUAD cells will inhibit the role of TAMs and control tumor growth cells promotes the secretion of chemokines and polarizing factors through activating PI3K/AKT/NF-κB pathway Notably, the M2 polarization of TAMs can also be prevented by inhibiting A2aR in vitro.
- [Inhibitory effect of downregulating G protein-coupled receptor class C group 5 member A expression on lipopolysaccharide-induced inflammatory response in human gingival fibroblasts]
staining were used to further investigate the activation of nuclear factor-kappa B (NF-κB) signaling pathway The siGPRC5A+LPS group (0.39±0.03, 1.06±0.16) also inhibited the increase of GPRC5A at both gene and cytoplasm, and partially translocated to the nucleus under the stimulation of LPS. siGPRC5A was able to inhibit Conclusions: GPRC5A expression was upregulated in periodontitis, and GPRC5A knockdown inhibited LPS-induced Moreover, GPRC5A played a role in inflammation regulation by interacting with NF-κB signaling pathway
- Investigating isoform switching in RHBDF2 and its role in neoplastic growth in breast cancer
., either they are involved in negative regulation of EGFR ligands via the ERAD pathway or positively regulate EGFR ligands via the EGFR signalling pathway. However, pathways leading to TACE-dependent EGFR signalling pathways were more observant, specifically MAPK signalling pathways, GPCR signalling pathways, and toll-like receptor pathways. and cytoplasmic ribosomal protein pathways were significantly enriched.
- Mechanistic exploration of bioactive constituents in Gnetum gnemon for GPCR-related cancer treatment through network pharmacology and molecular docking
Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses were enrichment analysis revealed the promising therapeutic effects of these targets on GPCRs-related cancer pathways demonstrated the strong binding affinity of gnetin A, gnetin C, (-)-viniferin, and resveratrol dimer, thus inhibiting
- Comparative Analysis of the GNAI Family Genes in Glioblastoma through Transcriptomics and Single-Cell Technologies
Hence, identifying the crucial pathways and biomarkers for the treatment of GBM is of prime importance We conducted this study to identify the pathways associated with GBM. analyses were conducted to explore the role of GNAI3 in co-expressed genes and associated signaling pathways Notable pathways included "Cytoskeleton remodeling regulation of actin cytoskeleton organization by the kinase effectors of Rho GTPases" and "Immune response B cell antigen receptor (BCR) pathway".
- Ep 131 with Dr. Richard Premont
GRKs (particularly GRKs 4,5,6) and arrestins as GPCR regulators and as mediators of distinct signaling pathways position at Duke in Gastroenterology, where he remained until 2018 studying GPCRs and their signaling pathways My research focus is on understanding how distinct cellular signaling pathways interact and are coordinated system, the coordination of heterotrimeric G protein, small GTP-binding protein and protein kinase pathways S-nitrosylation as a signaling post-translational modification in mediating and regulating cellular signaling pathways
- Ep 132 with Dr. Richard Premont
GRKs (particularly GRKs 4,5,6) and arrestins as GPCR regulators and as mediators of distinct signaling pathways position at Duke in Gastroenterology, where he remained until 2018 studying GPCRs and their signaling pathways My research focus is on understanding how distinct cellular signaling pathways interact and are coordinated system, the coordination of heterotrimeric G protein, small GTP-binding protein and protein kinase pathways S-nitrosylation as a signaling post-translational modification in mediating and regulating cellular signaling pathways
- Ep 130 with Dr. Richard Premont
GRKs (particularly GRKs 4,5,6) and arrestins as GPCR regulators and as mediators of distinct signaling pathways position at Duke in Gastroenterology, where he remained until 2018 studying GPCRs and their signaling pathways My research focus is on understanding how distinct cellular signaling pathways interact and are coordinated system, the coordination of heterotrimeric G protein, small GTP-binding protein and protein kinase pathways S-nitrosylation as a signaling post-translational modification in mediating and regulating cellular signaling pathways
- Ep 133 with Dr. Richard Premont
GRKs (particularly GRKs 4,5,6) and arrestins as GPCR regulators and as mediators of distinct signaling pathways position at Duke in Gastroenterology, where he remained until 2018 studying GPCRs and their signaling pathways My research focus is on understanding how distinct cellular signaling pathways interact and are coordinated system, the coordination of heterotrimeric G protein, small GTP-binding protein and protein kinase pathways S-nitrosylation as a signaling post-translational modification in mediating and regulating cellular signaling pathways
- In Silico Design of Novel RGS2-Galpha-q Interaction Inhibitors with Anticancer Activity
< GPCR News < GPCRs in Oncology and Immunology In Silico Design of Novel RGS2-Galpha-q Interaction Inhibitors We sought to develop RGS2 inhibitors as potential chemotherapeutic agents utilizing structure-based drug Whole cell assays showed the top 10 ranking compounds, AJ-1-AJ-10, to inhibit RGS2-Gαq interactions. All 10 compounds inhibited the growth of several RGS2 expressing cancers in cell culture assays. In addition, AJ-3 inhibited the migration of LNCaP prostate cancer cells in wound healing assays.
- GPR176 Promotes Cancer Progression by Interacting with G Protein GNAS to Restrain Cell Mitophagy in Colorectal Cancer
GPR176 is confirmed to activate the cAMP/PKA signaling pathway and modulate mitophagy, promoting CRC The GPR176/GNAS complex inhibits mitophagy via the cAMP/PKA/BNIP3L axis, thereby promoting the tumorigenesis
- Blockade of vasoactive intestinal peptide receptor 2 (VIPR2) signaling suppresses cyclin D1-dependent cell-cycle progression in MCF-7 cells
Treatment with the ERK-specific kinase (MEK) inhibitor U0126 and the class I PI3K inhibitor ZSTK474 decreased more than treatment with U0126 or ZSTK474 alone and did not affect the effect of the mixture of these inhibitors suggest that VIPR2 signaling regulates cyclin D1 levels through the cAMP/PKA/ERK and PI3K/AKT/GSK3β pathways
- miR-19a may function as a biomarker of oral squamous cell carcinoma (OSCC) by regulating the signaling pathway of miR-19a/GRK6/GPCRs/PKC in a Chinese population
-19a may function as a biomarker of oral squamous cell carcinoma (OSCC) by regulating the signaling pathway
- Ultrasensitive dose-response for asbestos cancer risk implied by new inflammation-mutation model
to adaptively initiate an apoptosis, inflammasome, Nrf2-ARE anti-oxidant, or heat-shock activation pathway Such switches exhibit nonlinear signal-activation relationships. requisite co-initiator (acting together with as few as two somatic mutations) of the most efficient pathway
- Role and recent progress of P2Y12 receptor in cancer development
Meanwhile, P2Y12R inhibitors can inhibit this effect, suggesting that P2Y12R may be a potential therapeutic P2Y12R is involved in cancer development and metastasis, while P2Y12R inhibitors are effective in inhibiting However, a new study suggests that long-term use of P2Y12R inhibitors may increase the risk of cancer We explored the role of P2Y12R inhibitors in different tumors and the latest advances by summarizing the basic and clinical studies on the effects of P2Y12R inhibitors on tumors."
- Spliceosome mutations are associated with clinical response in a phase 1b/2 study of the PLK1 inhibitor onvansertib in combination with decitabine in relapsed or refractory acute myeloid leukemia
Immunology Spliceosome mutations are associated with clinical response in a phase 1b/2 study of the PLK1 inhibitor A phase 1b trial of the PLK1 inhibitor onvansertib (ONV) combined with decitabine (DAC) demonstrated patients achieved complete remission, with or without hematologic count recovery (CR/CRi), and 32% exhibited PLK1 inhibition with ONV in combination with DAC could be a potential therapy in R/R AML patients, particularly
- GPR143 controls ESCRT-dependent exosome biogenesis and promotes cancer metastasis
controls the endosomal sorting complex required for the transport (ESCRT)-dependent exosome biogenesis pathway quantitative proteomic and RNA profiling of exosomes in human cancer cell lines showed that the GPR143-ESCRT pathway metastasis by secreting exosomes and increasing cancer cell motility/invasion through the integrin/FAK/Src pathway
- Targeting adenosine signaling for immuno-oncology
Potent inhibitors of ADO signaling are currently being tested in cancer patients, including in randomized adenosine-producing ectonucleotidases and adenosine signaling and discuss unexpected links between the adenosinergic pathway
- Prediction of survival and immunotherapy response by the combined classifier of G protein-coupled receptors and tumor microenvironment in melanoma
analysis, bioinformatic analysis and luciferase assays were performed to establish a potential signaling pathway over-expression of miR-19a could regulate the signaling between GRK6, GPR39 and PKC via the signaling pathway development of innovative therapeutic interventions aimed at regulating GRK6 and its downstream signaling pathways
- Unbiased multitissue transcriptomic analysis reveals complex neuroendocrine regulatory networks mediated by spinal cord injury-induced immunodeficiency
Cxcl10, Tnfaip3, Icam1, Fcgr2b, Ager, Dusp10, and Mapkapk2) were significantly enriched in inflammatory pathways downregulated genes (hub genes: Grm4, Nmu, P2ry12, rt1-bb1, Oprm1, Zfhx2, Gpr83, and Chrm2) were enriched in pathways related to inhibitory Gi-mediated G protein-coupled receptor (Gi-GPCR) neurons and neuropeptide changes Gi-mediated G protein-coupled receptors in the HPA axis and neuropeptide production by the hypothalamus are inhibited
- Deciphering a GPCR-lncRNA-miRNA Nexus: Identification of an Aberrant Therapeutic Target in Ovarian Cancer
More significantly, intratumoral delivery of UCA1-specific siRNAs inhibits the growth of cisplatin-refractory Song , Danny N Dhanasekaran Tags GPCR , High Grade Serous Ovarian Carcinoma , Let-7 miRNAs , Oncogenic Pathways
- Biochemical pharmacology of adenylyl cyclases in cancer
Understanding the signaling pathways involved in cancer progression is essential for the discovery of In addition, we highlight inhibitors of AC-related signaling that are currently under investigation,
- Ep 82 with Dr. Lauren M. Slosky
Because BAMs engage less well-conserved allosteric sites and exert pathway-specific effects on receptor signaling, they are exciting tools for linking distinct signaling pathways with their physiological Yamamura Endowed Fellowship in Pharmacology, an NIH F32 Postdoctoral Fellowship, and an NIH K99/R00 Pathway
- GPR37 expression as a prognostic marker in gliomas: a bioinformatics-based analysis
GPR37 is an orphan G protein-coupled receptor (GPCR) that is implicated in different physiological pathways regulation of macrophage derived foam cell differentiation, negative regulation of T cell receptor signaling pathway , neuroactive ligand receptor interaction, calcium signaling pathway, and negatively associated with
- Session VIII * | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
parallel differential expression of kidney proteins in GPR110 KO and WT mice by label-free LC-MS/MS and pathway Importantly, the signaling pathways underlying sexual reproduction in these different contexts have not suggest that Cupidon prevents sexual reproduction in S. rosetta under high nutrient availability, by inhibiting
- PAXIP1-AS1 is associated with immune infiltration and predicts poor prognosis in ovarian cancer
signaling by Interleukins, GPCR-ligand binding, G alpha I signaling events, VEGFAVEGFR-2 signaling pathway , naba secreted factors, Class A 1 Rhodopsin-Like Receptors, PI3K-Akt signaling pathway, and Focal Adhesion-PI3K-Akt-mTOR-signaling pathway were differentially enriched in PAXIP1-AS1 high expression phenotype.
- LPA1-mediated inhibition of CXCR4 attenuates CXCL12-induced signaling and cell migration
< GPCR News < GPCRs in Oncology and Immunology LPA1-mediated inhibition of CXCR4 attenuates CXCL12-induced Coexpression of LPA1 with CXCR4 reduced CXCL12-mediated cAMP inhibition, ERK activation, Gαi/o activation LPA or alkyl-OMPT inhibited CXCL12-induced migration in various cancer cells that endogenously express Ultimately, complete inhibition of cell migration toward CXCL12 and alkyl-OMPT was only achieved in the Moreover, our findings propose a therapeutic potential in combined CXCR4 and LPA1 inhibitors for cancer